The three years of the epidemic have been like a mirror, reflecting the beautiful and warmth of the world and a lot of ugly things.
Some time ago, "Zhang Shanshan" became popular, but unexpectedly exposed the ugly side of the nucleic acid testing industry. It frequently commits fraud and violates regulations, but makes a lot of money, and there is capital behind it. With the introduction of the "new ten" epidemic prevention measures, nucleic acid testing left the market, but unexpectedly, the pharmaceutical factory immediately took over, raised its sickle, and started the harvest.
In the past few days, various " COVID-19 drug hoarding guide" and "drug hoarding list" have been circulating in Moments and WeChat groups. Many people accept all the orders and start stocking up a large number of drugs. "Old-branded magical medicine" Lianhua Qingwen is the most popular. It has developed into a difficult-to-find drugstore and drug e-commerce platform.
In Shijiazhuang, a pharmacy sells 400,000 boxes a day. Since December 5, Beijing has invested 400,000 boxes of Lianhua Qingwen Granules and capsules to the market every day. On December 8, Lianhua Qingwen Capsules sold 828,000 pieces on the JD Health platform, ranking first in the sales list of over-the-counter medicine .
Lianhua Qingwen has become a hot commodity, and some merchants are ready to make "epidemic wealth" and constantly raise prices to harvest consumers. Some people have reported that the sales price of Lianhua Qingwen once rose to six times the original price.
Unconsciously, Lianhua Qingwen became the " miracle medicine for epidemic prevention". It seemed that with it, you can "drug to cure the disease". But in fact, Lianhua Qingwen can neither treat the new crown nor prevent the new crown. It is just a common cold medicine.
So, how did Lianhua Qingwen get onto the altar? Is there capital behind it working? Today we will dig deeper together.
Lianhua Qingwen Capsules are founded in Yiling Pharmaceutical in Wu Yiling . was developed by two historical prestigious agents in 2003. was originally intended to be used in SARS infected people, but because it was approved for market launch in May 2004, it failed to catch up with this wave. Since then, Lianhua Qingwen Capsules have been sold tepid.
In 2009, Lianhua Qingwen Capsules ushered in their first chance. In this year, Lianhua Qingwen Capsules were included in the type A H1N1 influenza diagnosis and treatment plan. The sales volume of increased from 176 million pills in the previous year to 1.382 billion pills, and sales volume soared from 60 million yuan to 500 million yuan, and increased by 670% year-on-year. The proportion of sales in Yiling Pharmaceutical's revenue has rapidly increased from 7.04% to 31.16%.
However, after 2010, influenza A was controlled, and Lianhua Qingwen Capsules sales fell to a low again. However, unexpectedly, a few years later, Lianhua Qingwen Capsules ushered in another opportunity, that is, the outbreak of the new crown epidemic. This time, Lianhua Qingwen Capsules not only seized the opportunity, but also entered the altar and directly became the god.
It is understood that Lianhua Qingwen has been included in the "Diagnosis and Treatment Plan for the New Coronavirus Pneumonia (Trial Fourth/Fifth/Sixth/Eighth/Nine Edition)" and other diagnosis and treatment plans. Subsequently, Lianhua Qingwen's sales began to take off. In 2020, Lianhua Qingwen's sales reached 3.431 billion yuan, a year-on-year increase of 167%. From 2020 to the first half of 2022, the sales of anti-cold drugs mainly composed of Lianhua Qingwen were 4.256 billion yuan, 4.108 billion yuan and 2.553 billion yuan respectively, accounting for 48.46%, 40.60% and 45.87% of Yiling Pharmaceutical's revenue, becoming the company's largest business.
Some people say that Lianhua Qingwen is popular because it has received official recommendations. But in fact, in each version of the diagnosis and treatment plan, there are many recommended drugs, not just Lianhua Qingwen. For example, in the ninth edition, among the recommended Chinese patent medicines, in addition to Lianhua Qingwen, there are also Jinhua Qinggan Granules and Shufeng Jiedu Capsules .
In the "Catalogue of Drugs for People with New Coronavirus Infections (First Edition)" released today, 108 kinds of Chinese and Western medicines are recommended, including 41 Western medicines and 67 Chinese medicines. There are 23 kinds of Chinese medicines for fever alone, including Lianhua Qingwen.
But why has only Lianhua Qingwen been "for the sake of the gods" in the past three years, and is still buying today. Even if the price is increased, you have to buy . You would rather be cut off than buy other medicines of the same type.
To put it bluntly, marketing is better. Taking advantage of the epidemic, it was rumored that Lianhua Qingwen was recommended by WHO , which was questioned by Wang Sicong and caused a wave of heated discussion. Then, in the temporary cabin, even Hua Qingwen basically ranked first among various drug recommendations. Now that the new ten new epidemic prevention and control measures have been issued, many marketing accounts have released "A few boxes of Lianhua Qingwen are prepared for any accidents", "Are you ready for Lianhua Qingwen?"
After repeated dissemination and guidance over the past three years, Lianhua Qingwen has established a cognition in the minds of many people. There must be Lianhua Qingwen for preparation of medicine, and there must be a few more boxes.
Normally, it is understandable to prepare some medicine, but it is completely unnecessary to stock up a few boxes or more than a dozen boxes, and there is no need to buy Lianhua Qingwen at a price increase. There are many medicines that can be replaced. However, there are always endless leeks, which makes capital profitable.
Lianhua Qingwen's sales are booming, and Yiling Pharmaceutical's stock price has risen sharply, becoming the new "Moutai among Medicines". Wu Yiling, founder of , has increased his net worth from 8.5 billion yuan in 2019 to 23 billion yuan in 2022, becoming the richest academician in China.
2003, we grabbed vinegar, salt, and isatis root . 20 years later, we grabbed masks and Lianhua Qingwen, and history is always amazingly similar.
However, you always have to pay it back when you come out. If you are thinking about cutting leeks, it will eventually retaliate on yourself. Wuhan Municipal Market Supervision Bureau issued guidelines for home treatment of new coronavirus infection, saying that Lianhua Qingwen Capsules have hundreds of alternative drugs, and Yiling Pharmaceutical's stock price once fell by more than 5%.
Lianhua Qingwen, it is time to step down from the altar and return to its normal position.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-